EXPRESSIONEDITS LTD

Active Altrincham

Research and experimental development on biotechnology

14 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
E

EXPRESSIONEDITS LTD

Research and experimental development on biotechnology

Founded 19 Jul 2021 Active Altrincham, United Kingdom 14 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 20 Aug 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 4 Sept 2025 Next due 9 Sept 2026 4 months remaining
Net assets £7M £6M 2024 year on year
Total assets £7M £6M 2024 year on year
Total Liabilities £120K £83K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for EXPRESSIONEDITS LTD (13517470), an active life sciences and medical technology company based in Altrincham, United Kingdom. Incorporated 19 Jul 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£6.71M

Increased by £5.58M (+494%)

Net Assets

£7.17M

Increased by £5.96M (+493%)

Total Liabilities

£120.04k

Increased by £82.64k (+221%)

Turnover

N/A

Employees

14

Increased by 4 (+40%)

Debt Ratio

2%

Decreased by 1 (-33%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2

Investors (7)

Investor NameInvestor SinceParticipating Rounds
Investor 4Dec 2021Seed, Pre-Seed
Investor 1May 2024Seed
Investor 2May 2024Seed

Share Capital

Share Capital

Share allotments and capital structure

5 Allotments 18,487,732 Shares £10.30m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
3 Apr 202412,499,998£7.50m£0.6
19 Oct 202216,750£0.017£0
1 Jun 20224,696,726£2.80m£0.597
1 Jun 20221,272,258£1.272£0
19 Jul 20212,000£0.2£0

Officers

Officers

2 active 1 resigned
Status
Allan BradleyDirectorBritishUnited Kingdom661 Jun 2022Active
Paul BolnoDirectorAmericanUnited States524 Nov 2024Active

Shareholders

Shareholders (19)

Kart Tomberg
21.5%
6,125,000
Redalpine Capital Vii S.c.s. Sicav-raif
14.6%
4,166,666

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Kärt Tomberg

Ceased 10 Apr 2024

Ceased

Allan Bradley

Ceased 1 Jun 2022

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
5 Sept 2025OfficersChange to director Professor Allan Bradley on 2025-07-01
4 Sept 2025Confirmation StatementConfirmation statement made on 2025-08-26 with no updates
4 Sept 2025OfficersChange to director Dr Michael Sidler on 2025-09-01
20 Aug 2025AccountsAnnual accounts made up to 2024-12-31
10 Dec 2024OfficersTermination of Jason Daniel Whitmire as director on 2024-12-06
5 Sept 2025 Officers

Change to director Professor Allan Bradley on 2025-07-01

4 Sept 2025 Confirmation Statement

Confirmation statement made on 2025-08-26 with no updates

4 Sept 2025 Officers

Change to director Dr Michael Sidler on 2025-09-01

20 Aug 2025 Accounts

Annual accounts made up to 2024-12-31

10 Dec 2024 Officers

Termination of Jason Daniel Whitmire as director on 2024-12-06

Recent Activity

Latest Activity

Change to director Professor Allan Bradley on 2025-07-01

7 months ago on 5 Sept 2025

Confirmation statement made on 2025-08-26 with no updates

7 months ago on 4 Sept 2025

Change to director Dr Michael Sidler on 2025-09-01

7 months ago on 4 Sept 2025

Annual accounts made up to 2024-12-31

8 months ago on 20 Aug 2025

Termination of Jason Daniel Whitmire as director on 2024-12-06

1 years ago on 10 Dec 2024